The Effect of beta-blockade on objectively measured physical fitness in patients with abdominal aortic aneurysms--A blinded interventional study

Br J Anaesth. 2015 Jun;114(6):878-85. doi: 10.1093/bja/aev026. Epub 2015 Feb 24.

Abstract

Background: Perioperative beta-blockade is widely used, especially before vascular surgery; however, its impact on exercise performance assessed using cardiopulmonary exercise testing (CPET) in this group is unknown. We hypothesized that beta-blocker therapy would significantly improve CPET-derived physical fitness in this group.

Methods: We recruited patients with abdominal aortic aneurysms (AAA) of <5.5 cm under surveillance. All patients underwent CPET on and off beta-blockers. Patients routinely prescribed beta-blockers underwent a first CPET on medication. Beta-blockers were stopped for one week before a second CPET. Patients not routinely taking beta-blockers underwent the first CPET off treatment, then performed a second CPET after commencement of bisoprolol for at least 48 h. Oxygen uptake (.VO2) at estimated lactate threshold and .VO2 at peak were primary outcome variables. A linear mixed-effects model was fitted to investigate any difference in adjusted CPET variables on and off beta-blockers.

Results: Forty-eight patients completed the study. No difference was observed in .VO2 at estimated lactate threshold and .VO2 at peak; however, a significant decrease in .VE/.VCO2 at estimated lactate threshold and peak, an increase in workload at estimated lactate threshold., O2 pulse and heart rate both at estimated lactate threshold and peak was found with beta-blockers. Patients taking beta-blockers routinely (chronic group) had worse exercise performance (lower .VO2 ).

Conclusions: Beta blockade has a significant impact on CPET-derived exercise performance, albeit without changing .VO2 at estimated lactate threshold and.VO2 at peak. This supports performance of preoperative CPET on or off beta-blockers depending on local perioperative practice.

Clinical trial registration: NCT 02106286.

Trial registration: ClinicalTrials.gov NCT02106286.

Keywords: abdominal aortic aneurysm; anaerobic threshold; beta-blockers; cardiopulmonary exercise test; fitness; surgery.

Publication types

  • Clinical Trial
  • Observational Study

MeSH terms

  • Adrenergic beta-Antagonists / therapeutic use*
  • Aged
  • Anaerobic Threshold / drug effects
  • Aortic Aneurysm, Abdominal / drug therapy*
  • Aortic Aneurysm, Abdominal / physiopathology*
  • Bisoprolol / therapeutic use
  • Exercise Test
  • Female
  • Heart Rate / drug effects
  • Humans
  • Lactic Acid / blood
  • Male
  • Oxygen Consumption / drug effects
  • Perioperative Care
  • Physical Fitness*
  • Prospective Studies
  • Spirometry

Substances

  • Adrenergic beta-Antagonists
  • Lactic Acid
  • Bisoprolol

Associated data

  • ClinicalTrials.gov/NCT02106286